Olfactory impairment in posterior cortical atrophy by Witoonpanich, P et al.
LETTER
Olfactory impairment in
posterior cortical atrophy
INTRODUCTION
Olfactory dysfunction develops in many
neurodegenerative diseases, and is an early
feature of the most common neurodegen-
erative disorder, Alzheimer’s disease
(AD).1–5 Anatomically, the central olfactory
pathways traverse brain regions implicated
in the common neurodegenerative diseases,
including the mesial temporal and inferior
frontal lobes.6–10 Phenotypically, AD shows
substantial diversity with several important
variant syndromes, notably posterior cor-
tical atrophy (PCA),11 which is under-
pinned by AD pathology in over 70% of
cases across series. Olfactory impairment in
PCA might act as an early signal of under-
lying AD pathology in these clinically atyp-
ical cases; while if olfactory processing were
spared in PCA, this would imply that olfac-
tion depends chieﬂy on disease topography.
However, there is presently very little infor-
mation concerning olfaction in PCA.
Here we compared olfactory function
prospectively in cohorts of patents
with PCA and typical AD (tAD).
Neuroanatomical associations of odour
identiﬁcation were assessed using voxel-
based morphometry (VBM). We hypothe-
sised that PCA would be associated with
olfactory impairment qualitatively similar
to tAD, but less severe (reﬂecting differen-
tial involvement of olfactory cortex); and
that deﬁcits of odour identiﬁcation in
both syndromes correlate with grey matter
loss in anteromedial temporal and inferior
frontal lobes.2 6–10
METHODS
Fifteen patients fulﬁlling consensus cri-
teria for PCA,11 10 patients fulﬁlling The
National Institute of Neurological and
Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA)
criteria for tAD and 32 healthy control
(HC) subjects participated. Cerebrospinal
ﬂuid (CSF) measurements, available for
four patients with PCA, revealed a raised
total-τ:β-amyloid ratio (>1) in each case,
consistent with underlying AD. Informed
consent was obtained from all subjects
and the study had local ethics committee
approval.
All subjects had a comprehensive
general neuropsychological assessment
which corroborated the clinical impres-
sion in both disease groups (see online
supplementary table S1). Further details
about the behavioural assessments are in
online supplementary material.
Olfactory processing was assessed
using the 40-item, four-alternative-forced-
choice University of Pennsylvania Smell
Identiﬁcation Test (UPSIT: British version).12
We modiﬁed the standard UPSIT in two
ways: on each trial, the subject was asked to
categorise the source of the odour as edible
or inedible (see online supplementary
table S2) before identifying it; and target-foil
choices were name-picture combinations
rather than odour names alone, to maximise
available response cues. Group differences
were assessed using analysis of variance
(ANOVA) or χ2 tests (Stata V.12.1), adjusting
for cognitive severity, verbal processing mea-
sures, age and gender.
Twelve patients with PCA and eight
patients with tAD had T1-weighted volu-
metric magnetic resonance (MR) brain
images acquired on a 3.0T Siemens Trio
scanner. VBM was performed using SPM8
(http://www.ﬁl.ion.ucl.ac.uk/spm) following
previously described procedures (see online
supplementary material). Linear regression
was used to examine voxel-wise associa-
tions between regional grey matter volume
and odour identiﬁcation performance
(age-normed and gender-normed percentile
score) across the combined patient cohort,
within the PCA subgroup, and between
syndromic subgroups, incorporating syn-
dromic group, mini-mental state examin-
ation (MMSE) score and total intracranial
volume as covariates. Statistical parametric
maps were assessed thresholded over the
whole brain volume and after multiple-
comparisons correction over small volumes
of interest (right and left anteromedial tem-
poral lobes and orbitofrontal cortex) speci-
ﬁed in our prior anatomical hypotheses.
RESULTS
For both patient groups, mean odour cat-
egorisation and identiﬁcation raw scores
were signiﬁcantly lower than the HC
group (p<0.001; ﬁgure 1A, online
supplementary table S1; individual data in
online supplementary ﬁgure S1). Based on
published UPSIT norms,12 four patients
with PCA (26%) and three patients with
tAD (30%) scored <5th percentile. Mean
raw or percentile scores did not differ sig-
niﬁcantly (p>0.1) between the PCA and
tAD groups. After correction for guessing,
mean odour identiﬁcation scores were
higher than mean categorisation scores for
PCA patients as well as HC subjects (see
online supplementary table S1). An error
analysis of individual odour items in the
identiﬁcation test revealed a qualitatively
similar proﬁle of errors across all groups
(see online supplementary ﬁgure S2).
Statistical parametric maps of signiﬁcant
regional grey matter associations of odour
identiﬁcation performance are displayed
in ﬁgure 1B (quantitative data summarised
in online supplementary table S3). Across
the combined patient cohort, performance
on the odour identiﬁcation task was posi-
tively associated with regional grey matter
volume in right entorhinal cortex and para-
hippocampal gyrus (p<0.05 FWE-corrected
over the temporal lobe volume of interest).
At a more lenient threshold (p<0.001
uncorrected over the whole brain volume),
additional associations were present in
more distributed, predominantly right-sided
cerebral areas, including hippocampus,
posterior inferior temporal gyrus/sulcus,
temporo-parieto-occipital junction and pre-
motor cortex (see online supplementary
table S3). Similar grey matter associations of
odour identiﬁcation performance were
identiﬁed for the PCA subgroup alone
(p<0.001 uncorrected over the whole brain
volume; online supplementary table S3).
Direct comparison between the PCA and
tAD subgroups revealed no signiﬁcant
between-group differences in regional
grey matter correlations of olfactory
performance.
DISCUSSION
Here we have demonstrated deﬁcits of
odour identiﬁcation and categorisation in
patients with PCA relative to HCs. A
similar proportion (around 30%) of
patients with PCA and tAD in this study
had an absolute deﬁcit of odour identiﬁ-
cation referenced to published age and
gender norms and taking account of asso-
ciated cognitive impairment. Olfactory
impairment was similar quantitatively and
qualitatively in the PCA and tAD groups.
To the extent that PCA manifests under-
lying AD, the ﬁndings imply that olfactory
impairment is a hallmark of AD path-
ology. It is noteworthy that only a minor-
ity of patients in both phenotypical
groups here reported olfactory symptoms,
suggesting that in many cases olfactory
impairment is ‘subclinical’. Mean cor-
rected odour identiﬁcation scores were
higher than categorisation scores in the
HC and PCA groups: this unexpected
ﬁnding might hold clues to the cognitive
organisation of olfactory knowledge or
the cognitive strategies engaged by these
tests, and would warrant further study in
larger populations. Odour identiﬁcation
tasks tend to be cognitively demanding
and therefore potentially susceptible to
executive and attentional deﬁcits that
accompany AD.3 13
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The deﬁcit of odour identiﬁcation
identiﬁed here was associated with
regional grey matter volume in a cerebral
network focussed on the right anterome-
dial temporal lobe. The most robust
neuroanatomical associations occurred in
parahippocampal gyrus and entorhinal
cortex: areas linked to odour identiﬁca-
tion in healthy human subjects.6 7 Right
temporal lobe degeneration has been
associated previously with clinical deﬁcits
of odour recognition.2 Additional, less
robust anatomical associations here
included more posterior superior tem-
poral and adjacent parietal areas, and
premotor cortex: similar areas have been
shown previously to be engaged in odour
analysis,14 olfactory working memory15
and snifﬁng.16 An overlapping cerebral
network has been implicated in the
pathogenesis of tAD and PCA.11
Olfactory dysfunction may have a charac-
teristic network signature that transcends
conventional phenotypic boundaries and
could potentially be used to predict AD
pathology in the face of phenotypical
variation. However, any claim to patho-
logical speciﬁcity carries the important
caveat that olfactory impairments have
been deﬁned for a range of
non-Alzheimer neurodegenerative path-
ologies (notably, parkinsonian and other
disorders in the frontotemporal lobar
degeneration spectrum.3–5 10 Rather than
olfactory impairment per se, the signa-
ture of the impairment may be more
likely to predict underlying pathology.3
In addition, the present study was under-
powered to detect subtle behavioural or
neuroanatomical differences between the
syndromic groups.
This study has several limitations that
suggest directions for future work. We did
not assess perceptual encoding of odours:
it will be important to compare associative
and perceptual olfactory functions directly,
to assess the extent to which these differ-
ent factors contribute to olfactory impair-
ment in AD. The patient groups studied
here were relatively small: there is a need
to extend the work to larger patient
cohorts spanning other AD phenotypes
(eg, logopenic aphasia) and in direct com-
parison with other neurodegenerative path-
ologies.3 Although PCA is usually
attributable to AD pathology, neuropatho-
logical substrates in the present PCA
cohort remain to be determined. Future
longitudinal studies in different AD pheno-
types (ideally, including presymptomatic
carriers of AD-causing genetic mutations)
will be required to assess onset and evolu-
tion of olfactory deﬁcits.
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Figure 1 Summary of behavioural
and neuroanatomical ﬁndings. (A)
Distribution plots of olfactory
performance comparing mean, median,
IQR and full range of odour
categorisation and identiﬁcation of raw
scores of subjects in the healthy
control (HC), posterior cortical atrophy
(PCA) and typical Alzheimer’s disease
(tAD) groups. (B) Statistical parametric
maps (SPMs) of regional grey matter
atrophy associated with odour
identiﬁcation performance across the
combined PCA and tAD cohorts. SPMs
are shown rendered on axial (left,
middle panels) and sagittal (right
panel) sections of the mean
normalised structural T1-weighted
brain MR image. The axial sections
show the right hemisphere on the
right; the sagittal section is through
the right hemisphere. For display
purposes, SPMs have been thresholded
at p<0.001 uncorrected over the whole
brain volume; see online
supplementary table S3 for
associations attaining signiﬁcance after
multiple-comparisons correction. The
plane of each section is shown in
Montreal Neurological Institute (MNI)
coordinates in millimetres (mm).
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